When a bruise is not a bruise: chronic recurrent erythema nodosum of unidentified cause in a young woman
Keywords:
ERITEMA NUDOSO; PANICULITIS; ADULTO JOVEN; FIEBRE; RECURRENCIA; PREDNISONA; DIAGNÓSTICO DIFERENCIAL; ERYTHEMA NODOSUM; PANNICULITIS; YOUNG ADULT; FEVER; RECURRENCE; PREDNISONE; DIAGNOSIS, DIFFERENTIAL.Abstract
Introduction: erythema nodosum is the most common form of panniculitis. Although typically self-limiting, it can follow a chronic and recurrent course with no identifiable cause, posing both diagnostic and therapeutic challenges—particularly in settings where access to specialized diagnostic studies is limited.
Case presentation: a 25-year-old woman, who is a smoker and has iron-deficiency anemia, presented with a fever of up to 39°C lasting 9–10 days, accompanied by the successive appearance of painful, warm, erythematoviolaceous lesions—resembling ecchymoses—on both lower extremities. A superficial thrombotic event was initially suspected, and acetylsalicylic acid was prescribed. The patient was admitted for an etiological investigation. Findings included hypochromic anemia, mild leukopenia, an erythrocyte sedimentation rate (ESR) of 18 mm/h, and proteinuria; a chest X-ray was normal, and serological tests for syphilis and human immunodeficiency virus (HIV) were negative. As there was no response to non-steroidal anti-inflammatory drugs (NSAIDs), the patient was treated with prednisone (0.5 mg/kg/day), with a gradual taper. Over approximately 11 months of follow-up, she experienced recurrent, migratory outbreaks, with no sustained response to steroids and no identifiable underlying cause.
Conclusions: erythema nodosum can be chronic and recurrent without an identifiable cause, showing only partial or transient responses to anti-inflammatory drugs and steroids. This diagnosis should be considered when painful, bruise-like nodules appear on the lower extremities. In resource-limited settings, a meticulous clinical assessment and basic diagnostic tests can guide the diagnosis, while long-term follow-up allows for the ongoing re-evaluation of potential underlying causes.
Downloads
References
1. Pérez-Garza DM, Chávez-Álvarez S, Ocampo-Candiani J, Gómez-Flores M. Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol[internet]. 2021[citado 10/10/2026]; 22(3): 367-78. Disponible en: https://doi.org/10.1007/s40257-021-00592-w
2. Glover G, Wilson J, Leigh K, Miller B. Understanding erythema nodosum. J Dermatol Nurses Assoc[internet]. 2024[citado 10/10/2026]; 16(6): 228-31. Disponible en: https://www.ovid.com/jnls/jdnaonline/fulltext/10.1097/jdn.0000000000000814~understanding-erythema-nodosum-a-cutaneous-manifestation-of
3. Pérez-Carrillo V, Rondón-Carvajal J. Enfoque general del paciente con eritema nudoso. Rev CES Med [Internet]. 2020 [citado 01/10/2026]; 34(1): 53-63. Disponible en: https://www.redalyc.org/articulo.oa?id=261181960006
4. Benedetti J. Eritema nudoso [Internet]. Manual MSD versión para el hogar. Merck & Co., Inc.; 2024 [citado 01/10/2026]. Disponible en: https://www.msdmanuals.com/es/hogar/trastornos-de-la-piel/hipersensibilidad-y-trastornos-cut%C3%A1neos-reactivos/eritema-nudoso
5. Shah JT, Richardson WM, Caplan AS, Mazori DR, Femia AN. Clinical characteristics of erythema nodosum and associations with chronicity and recurrence. JAMA Dermatol[internet]. 2024[citado 10/10/2026]; 160(2):229-32. Disponible en: https://doi.org/10.1001/jamadermatol.2023.5306
6. Limtong P, Suchonwanit P, Chanprapaph K, Rutnin S. Clinicopathological characteristics related to etiologies of erythema nodosum: a 10-year retrospective study. Clin Cosmet Investig Dermatol[internet]. 2021[citado 10/10/2026]; 14:1819-29. Disponible en: https://doi.org/10.2147/ccid.s343351
7. Camero-Machín JC, Anuy-Echevarría K, Curbelo-Fajardo JC, Hernández-Concepción MI. Comportamiento clínico-epidemiológico del eritema nudoso en el Hospital Provincial Docente Clínico Quirúrgico León Cuervo Rubio. Rev Med Electrón [Internet]. 2021 [citado 01/10/2026]; 43(6):1506-20. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242021000601506
8. Camero-Machín JC, Anuy-Echevarría K, Curbelo-Fajardo JC, Giniebra-Marín GM. Caracterización clínico-epidemiológica del eritema nudoso. Folia Dermatol Cubana [Internet]. 2024 [citado 01/10/2026];18(1):e155. Disponible en: https://revfdc.sld.cu/index.php/fdc/article/view/155
9. Cortiguera Landa IM, Rioja Delgado EM, Barrera Martínez N, Martín Gómez R, Herranz Fernández-Tenllado D. Eritema nudoso. Form Med Contin Aten Prim[internet]. 2025[citado 10/10/2026]; 32(5):251-5. https://dialnet.unirioja.es/servlet/articulo?codigo=10302004
10. Domínguez-Gasca LG, Domínguez-Carrillo LG. Eritema nudoso. Aten Fam[internet]. 2023[citado 10/10/2026]; 24(3):231-5. https://repositorio.unam.mx/contenidos/4147247
11. Torralba-Morón Á, Alda-Bravo I. Causas de eritema nudoso en pacientes ingresados en un hospital español de tercer nivel. Actas Dermosifiliogr[internet]. 2020[citado 10/10/2026]; 111(8):683-7. https://doi.org/10.1016/j.ad.2018.12.012 .
12. Varas P, Antúnez-Lay A, Bernucci JM, Cossio L, González S, Eymin G. Eritema nodoso: causas más prevalentes en pacientes que se hospitalizan para estudio, y recomendaciones para el diagnóstico. Rev Med Chile[internet]. 2016[citado 10/10/2026]; 144(2):162-8. https://www.revistamedicadechile.cl/index.php/rmedica/article/view/4307 .
13. Rodríguez Hernández R, Alberteris Rodríguez A. Eritema nudoso como debut del lupus eritematoso sistémico. Reumatol Al Día[internet]. 2024[citado 10/10/2026];18(3):4. https://doi.org/10.62484/rad.v18i3.8660
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Rigoberto Pestana, Lázara Marliés Javiqué-Díaz

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who have published with this journal accept the following terms: authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons recognition license that allows third parties to share the work as long as its author is indicated and its first publication is this journal. Authors may adopt other non-exclusive license agreements for the distribution of the version of the published article (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) provided that the initial publication in this journal is indicated. Authors are permitted and encouraged to disseminate their article using Internet (e.g., in institutional telematic archives or on their website) before and during the submission process, which may lead to interesting exchanges and increased citations of the published work. (See The Effect of Open Access).

